- Home
- EYE vs BCRX Comparison
EYE vs BCRX Comparison
Compare EYE & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYE
- BCRX
- Stock Information
- Founded
- EYE 1990
- BCRX 1986
- Country
- EYE United States
- BCRX United States
- Employees
- EYE N/A
- BCRX N/A
- Industry
- EYE Ophthalmic Goods
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EYE Health Care
- BCRX Health Care
- Exchange
- EYE Nasdaq
- BCRX Nasdaq
- Market Cap
- EYE 1.9B
- BCRX 1.8B
- IPO Year
- EYE 2017
- BCRX 1994
- Fundamental
- Price
- EYE $23.48
- BCRX $8.27
- Analyst Decision
- EYE Buy
- BCRX Strong Buy
- Analyst Count
- EYE 9
- BCRX 10
- Target Price
- EYE $21.78
- BCRX $16.70
- AVG Volume (30 Days)
- EYE 2.2M
- BCRX 2.2M
- Earning Date
- EYE 08-06-2025
- BCRX 11-03-2025
- Dividend Yield
- EYE N/A
- BCRX N/A
- EPS Growth
- EYE N/A
- BCRX N/A
- EPS
- EYE N/A
- BCRX N/A
- Revenue
- EYE $1,885,540,000.00
- BCRX $557,506,000.00
- Revenue This Year
- EYE $8.92
- BCRX $41.37
- Revenue Next Year
- EYE $3.32
- BCRX $7.56
- P/E Ratio
- EYE N/A
- BCRX N/A
- Revenue Growth
- EYE 5.08
- BCRX 45.85
- 52 Week Low
- EYE $9.56
- BCRX $6.02
- 52 Week High
- EYE $25.67
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- EYE 49.22
- BCRX 43.55
- Support Level
- EYE $21.51
- BCRX $8.02
- Resistance Level
- EYE $25.05
- BCRX $8.68
- Average True Range (ATR)
- EYE 0.88
- BCRX 0.22
- MACD
- EYE -0.08
- BCRX 0.01
- Stochastic Oscillator
- EYE 55.65
- BCRX 37.88
About EYE National Vision Holdings Inc.
National Vision Holdings Inc is an optical retailer in the U.S. Its product portfolio includes eyeglasses and sunglasses, contact lenses, accessories, and other products. The company has two operating segments; Owned and Host segment includes company-owned brands America's Best and Eyeglass World, In America's Best stores, vision care services are provided by optometrists or by independent professional corporations and Host operating consist of Military and Fred Meyer which provide eye exams by independent optometrists, and the Legacy segment manages the operations of, and supplies inventory and lab processing services to Legacy retail Vision Centers. It earns a majority of its revenue from the Owned and Host segment.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.